Ebola survivors under the microscope: what happens after recovery?

NCT ID NCT04409405

Completed Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study in the Democratic Republic of the Congo followed 787 people who survived Ebola and their close contacts. Researchers tracked their health over time, looking for lingering virus, immune responses, and other infections. The goal was to better understand the long-term consequences of Ebola and how to prevent further spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could improve how we monitor and care for Ebola survivors and help prevent future outbreaks by understanding how the virus lingers or spreads.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove that any intervention works, and results may not apply to other regions or outbreaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ebola hemorrhagic fever

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EBOLA VIRUS DISEASE

Contacts and locations

Locations

Beni Hospital

Beni, Democratic Republic of the Congo
Butembo Hospital

Butembo, Democratic Republic of the Congo
Mambasa Hospital

Mambasa, Democratic Republic of the Congo
Mangina Hospital

Beni, Democratic Republic of the Congo

More trials for these conditions

Other studies related to the condition(s) this trial covers.